AQUESTIVE THERAPEUTICS INC

$AQST
Smart money positioned

6 of the Top-200 alpha managers hold $AQST as of the latest 13F snapshot.

13F holders
176
Insider buys · 90d
0
Congress · 90d
0

Smart Money · top-200 alpha cohort

6 holders · Q1 2026

$AQST is held by 6 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 0.00%, with an average of 0.00% of portfolio. Largest holder: ADAR1 Capital Management, LLC at 0.00%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Institutional holders

Top 10 of 176 · Source: 13F-HR
01
Crescent Grove Advisors, LLC
100.00% of portfolio
9,810,958 sh
02
Nomura Asset Management Co. Ltd.
0.02% of portfolio
5,640,764 sh
03
Banyan Capital Management, Inc.
4,161,724 sh
04
Siemens Pension Trust E V
0.02% of portfolio
2,900,570 sh
05
Brightline Capital Management, LLC
2,869,500 sh
06
EcoR1 Capital, LLC
0.71% of portfolio
2,625,000 sh
07
Axa S.a.
2,546,191 sh
08
Samsara BioCapital, LLC
1.83% of portfolio
2,500,000 sh
09
Castleview Partners, LLC
1.01% of portfolio
2,500,000 sh
10
State Street
2,462,778 sh
See all 176 13F holders · Pro →

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $AQST in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $AQST in the recent window.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 07:24 UTC.